The Reality of Medical Cannabis: Cost and Access

In November's The Cannabinoid Journal we bring together writers from four central groups; patients, GPs, industry leads and policy makers and hear the obstacles faced by each.

Establishing medical cannabis as a legitimate therapy in the UK will not be achieved through the action of any one group, but with the concerted efforts of multiple, mutually exclusive parties. If we are to be successful in achieving this, understanding this complex problem from each others perspectives will be central. 

In November’s The Cannabinoid Journal we bring together writers from four central groups; patients, GPs, industry leads and policy makers and hear the obstacles faced by each. Firstly on November 9th we hear from Carly Barton, a prominent patient and advocate describing the many barriers she and many other face, and how they may be overcome.